GSK Finally Lands Human Genome With Upped $3B Offer
Human Genome Sciences Inc. finally yielded to a sweetened, $3 billion takeover offer from British drugmaker GlaxoSmithKline PLC on Monday, ending a three-month battle involving six BigLaw firms and four Wall...To view the full article, register now.
Already a subscriber? Click here to view full article